A Humanized Aldolase Antibody for Selective Chemotherapy and Adaptor Immunotherapy
- 6 September 2003
- journal article
- Published by Elsevier in Journal of Molecular Biology
- Vol. 332 (4) , 889-899
- https://doi.org/10.1016/s0022-2836(03)00992-6
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Integrin αvβ3‐targeted therapy for Kaposi's sarcoma with an in vitro‐evolved antibodyThe FASEB Journal, 2002
- An Efficient Benchtop System for Multigram-Scale Kinetic Resolutions Using Aldolase AntibodiesChemistry – A European Journal, 2000
- Reconstructing Aldolase Antibodies to Alter Their Substrate Specificity and TurnoverJournal of the American Chemical Society, 2000
- A Catalytic Enantioselective Route to Hydroxy-Substituted Quaternary Carbon Centers: Resolution of Tertiary Aldols with a Catalytic AntibodyJournal of the American Chemical Society, 1999
- Analysis of Heavy and Light Chain Pairings Indicates that Receptor Editing Shapes the Human Antibody RepertoireJournal of Molecular Biology, 1999
- Aldolase Antibodies of Remarkable ScopeJournal of the American Chemical Society, 1998
- Design and production of novel tetravalent bispecific antibodiesNature Biotechnology, 1997
- Efficient Neutralization of Primary Isolates of HIV-1 by a Recombinant Human Monoclonal AntibodyScience, 1994
- Modification of an Elisa-Based procedure for affinity determination: correction necessary for use with bivalent antibody☆Molecular Immunology, 1987
- Replacing the complementarity-determining regions in a human antibody with those from a mouseNature, 1986